# Evaluation of [18F]APN-1607 as a PET Biomarker

> **NCT05005819** · PHASE1 · COMPLETED · sponsor: **Invicro** · enrollment: 12 (actual)

## Conditions studied

- Progressive Supranuclear Palsy
- Healthy Volunteers

## Interventions

- **DRUG:** [18F] APN-1607

## Key facts

- **NCT ID:** NCT05005819
- **Lead sponsor:** Invicro
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-25
- **Primary completion:** 2024-01-09
- **Final completion:** 2024-01-09
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2025-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05005819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05005819, "Evaluation of [18F]APN-1607 as a PET Biomarker". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT05005819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*